Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From Ameritrade (Financials) PTSC

As well What Turley noted was utter nonsense and can get him into a heck of a lot of trouble.

 I can not believe that  in this post_SOX era that a CEO could make those statements in a public forum

 Price is based on Future, not past, earnings and as of now the probability of 

future earnings is not high enough to give PTSC any valuation given that 

400 million  shares or so are issued, above the current book of 5 cents per share on 20 million in cash.

 at 47 cents PTSC is pricing in at least 100 million in immediate future earnings implying nearly 250 million TPL licenses over the next 18-24  months.  (remember we gotta pay fish off the top)

So when Turley notes that he doesn;t understand the valuation f PTSC he either needs 

a quick call on valuation from the Oracle of Omaha or he is full of crap or both

 

Now I bought 30K more shares last week based on the fact that

 the bolingers were breached on the downside and I had the first oversold condition in a long time.  But either Turley knows something is up or he's kust spewing nonsenseOf course the former will be fine

until I close my position but it does scare me when a CEO feels a need to pump the stock.

Find me one source that values share price based on past earnings and I'll retract 

it all but for now I am concerned 

 

 

 

Share
New Message
Please login to post a reply